EP0910382 - SQUALAMINE IN COMBINATION WITH OTHER ANTI-CANCER AGENTS FOR TREATING TUMORS [Right-click to bookmark this link] | |||
Former [1999/17] | TREATMENT OF CARCINOMAS USING SQUALAMINE IN COMBINATION WITH OTHER ANTI-CANCER AGENTS | ||
[2002/49] | Status | No opposition filed within time limit Status updated on 16.04.2004 Database last updated on 15.07.2024 | Most recent event Tooltip | 16.04.2004 | No opposition filed within time limit | published on 02.06.2004 [2004/23] | Applicant(s) | For all designated states GENAERA CORPORATION 5110 Campus Drive Plymouth Meeting, PA 19462 / US | [N/P] |
Former [2003/44] | For all designated states GENAERA CORPORATION 5110 Campus Drive Plymouth Meeting PA 19462 / US | ||
Former [2003/24] | For all designated states MAGAININ PHARMACEUTICALS INC. 5110 Campus Drive Plymouth Meeting PA 19462 / US | ||
Former [1999/17] | For all designated states MAGAININ PHARMACEUTICALS INC. 5110 Campus Drive Plymouth Meeting PA 19462 / US | Inventor(s) | 01 /
ZASLOFF, Michael 274 Linden Lane Merion Station, PA 19066 / US | 02 /
WILLIAMS, Jon 11 Darvel Drive Robbinsville, NJ 08691 / US | [1999/17] | Representative(s) | Goulard, Sophie, et al Cabinet ORES 36 Rue de St Pétersbourg 75008 Paris Cedex / FR | [N/P] |
Former [2003/23] | Goulard, Sophie, et al Cabinet ORES, 36,rue de St Pétersbourg 75008 Paris Cedex / FR | ||
Former [1999/17] | Mouget-Goniot, Claire Cabinet Orès, 6, Avenue de Messine 75008 Paris / FR | Application number, filing date | 97921396.4 | 25.04.1997 | [1999/17] | WO1997US07011 | Priority number, date | US19960016387P | 26.04.1996 Original published format: US 16387 P | [1999/17] | Filing language | EN | Procedural language | EN | Publication | Type: | A1 Application with search report | No.: | WO9740835 | Date: | 06.11.1997 | Language: | EN | [1997/47] | Type: | A1 Application with search report | No.: | EP0910382 | Date: | 28.04.1999 | Language: | EN | The application published by WIPO in one of the EPO official languages on 06.11.1997 takes the place of the publication of the European patent application. | [1999/17] | Type: | B1 Patent specification | No.: | EP0910382 | Date: | 11.06.2003 | Language: | EN | [2003/24] | Search report(s) | International search report - published on: | EP | 06.11.1997 | Classification | IPC: | A61K31/56, A61K45/00, A61P35/00, // (A61K45/00, 31:56) | [2002/49] | CPC: |
A61K31/575 (EP,US);
A61K33/243 (EP,US);
A61P35/00 (EP)
| C-Set: |
A61K31/575, A61K2300/00 (US,EP);
A61K31/575, A61K31/00 (US,EP);
A61K33/24, A61K2300/00 (EP,US);
A61K33/24, A61K31/575 (US,EP) |
Former IPC [1999/17] | A61K31/56 | Designated contracting states | AT, BE, CH, DE, DK, ES, FI, FR, GB, GR, IE, IT, LI, LU, MC, NL, PT, SE [1999/17] | Title | German: | SQUALAMIN IN KOMBINATION MIT ANDEREN ANTIKREBS-MITTELEN ZUR BEHANDLUNG VON TUMOREN | [2002/49] | English: | SQUALAMINE IN COMBINATION WITH OTHER ANTI-CANCER AGENTS FOR TREATING TUMORS | [2002/49] | French: | LA SQUALAMINE EN ASSOCIATION AVEC D'AUTRES AGENTS ANTICANCEREUX POUR LE TRAITEMENT DES TUMEURS | [2002/49] |
Former [1999/17] | BEHANDLUNG VON KARZINOMEN MIT SQUALAMINE KOMBINIERT MIT ANDEREN ANTIKREBS-MITTELEN | ||
Former [1999/17] | TREATMENT OF CARCINOMAS USING SQUALAMINE IN COMBINATION WITH OTHER ANTI-CANCER AGENTS | ||
Former [1999/17] | TRAITEMENT DES CARCINOMES PAR LA SQUALAMINE EN ASSOCIATION AVEC D'AUTRES AGENTS ANTICANCEREUX | Entry into regional phase | 22.10.1998 | National basic fee paid | 22.10.1998 | Designation fee(s) paid | 22.10.1998 | Examination fee paid | Examination procedure | 23.10.1997 | Request for preliminary examination filed International Preliminary Examining Authority: EP | 25.11.1998 | Amendment by applicant (claims and/or description) | 25.11.1998 | Examination requested [1999/17] | 23.05.2002 | Despatch of a communication from the examining division (Time limit: M04) | 05.09.2002 | Reply to a communication from the examining division | 31.10.2002 | Communication of intention to grant the patent | 06.02.2003 | Fee for grant paid | 06.02.2003 | Fee for publishing/printing paid | Opposition(s) | 12.03.2004 | No opposition filed within time limit [2004/23] | Fees paid | Renewal fee | 28.04.1999 | Renewal fee patent year 03 | 03.04.2000 | Renewal fee patent year 04 | 02.04.2001 | Renewal fee patent year 05 | 12.04.2002 | Renewal fee patent year 06 | 14.04.2003 | Renewal fee patent year 07 |
Opt-out from the exclusive Tooltip competence of the Unified Patent Court | See the Register of the Unified Patent Court for opt-out data | ||
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court. | Cited in | International search | [Y]JPS6133121 ; | [PYD]WO9640151 (MAGAININ PHARMA [US]) [PYD] 1-29* page 7, paragraph 3 - page 8, paragraph 1; claim 1 *; | [Y] - KONOVALOVA ET AL., "Increasing the therapeutic efficacy of antitumor drugs", CHEMICAL ABSTRACTS, (19890717), vol. 111, no. 3, Database accession no. 17264, XP002037635 [Y] 1-29 * abstract * | [ ] - IZV.AKAD.NAUK SSSR,SER.BIOL., (1989), vol. 3, pages 466 - 468 | [Y] - DATABASE WPI, 1, Derwent World Patents Index, vol. 86, no. 13, Database accession no. 86-085704, XP002037636 & JPS6133121 A 19860217 (NISSEI MARINE KOGYO) [Y] 1-29 * abstract * | [Y] - Biosis Previews Biosis no. 82085007, XP002037634 [Y] 1-29 * abstract * | [ ] - T.IKEKAWA ET AL., "Studies on antitumor activity of squalene and its related compounds", YAKUGAKU ZASSHI, (1986), vol. 7, pages 578 - 582 | [Y] - JANE HOLMES, "Shark cartilage for cancer treatment?", P AND T, (199603), vol. 21, no. 3, pages 159 - 160, XP000602614 [Y] 1-29 * the whole document * | [Y] - "Aminosterol antibiotic", CURR.OPIN.THER.PAT., (1993), vol. 3, no. 9, pages 1369 - 1370, XP002037633 [Y] 1-29 * abstract * |